FiercePharma is reporting that Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. (collectively “Takeda”), today announced that more than 96 percent of eligible claimants have opted into the ACTOS (pioglitazone HCl) product liability resolution program that was announced on April 28, 2015. Takeda now is evaluating the submissions to determine whether they satisfy various criteria specified under terms …
Takeda Offers Even More to Settle Actos: Total Settlement Reaches Even Greater Heights
Bloomberg is reporting today that Takeda is now offering $2.3 billion – $100 million more than was offered on April 1, 2015 – to settle the 8,000 Actos cases currently on file in state and federal courts across the U.S. This is equal to $287,500 per case which figures to be only $12,500 more per case than their previous offer. …
ACTOS UPDATE: Takeda Offers Massive Settlement for Actos Users
Bloomberg News is reporting that Takeda Pharmaceutical Co., Asia’s largest drugmaker, is offering a $2.2 billion settlement for the 8,000 Actos lawsuits filed in state and federal courts throughout the U.S. On an individual basis, the settlement amount figures to be $275,000 per lawsuit. As the T&T blog has reported in the past, Actos sales peaked in March 2011 at …
Takeda Told to Pay Punitive Damages in Actos Claims
A jury ordered Takeda Pharmaceutical Co. to pay $1.3 million in punitive damages to a former teacher who argued the drugmaker’s Actos diabetes medicine caused his bladder cancer, in the company’s fifth loss in trials over the drug. Jurors in state court in Philadelphia deliberated more than two hours Friday before concluding that Osaka, Japan-based Takeda must pay the punitive …
Takeda Jury in Philadelphia Told Actos Responsible for Man’s Cancer
A Philadelphia jury was sent to deliberate Wednesday afternoon after being urged to find that Takeda Pharmaceuticals Inc. had willfully worked to obscure evidence linking the blockbuster diabetes drug Actos to an increased risk of bladder cancer. Miller Firm LLC attorney Michael Miller asked the jury during closing arguments to return a verdict in favor of plaintiff John Kristufek, who …
Pa. Judge Won’t Strike Actos Verdict Against Takeda
Pennsylvania judge has declined to overturn a $2 million verdict awarded in October to a plaintiff who claimed that the Takeda Pharmaceuticals Inc. drug Actos was a significant contributor to her developing bladder cancer. In an order docketed on Friday, Philadelphia Court of Common Pleas Judge Shelly Robins New rejected the company’s post-trial motions, in which they had argued that …
Actos Caused Consumer’s Bladder Cancer, Philly Jury Hears
A Philadelphia jury heard opening arguments on Wednesday in a case against Takeda Pharmaceutical Co., the latest in a string of suits against the drugmaker, alleging that a retired high-school teacher developed bladder cancer after taking the diabetes drug Actos. Miller Firm LLC attorney Michael Miller told the jury that warnings issued beginning in June 2011 about the risks associated …
Eli Lilly, Takeda Win Dismissal Of Ark. Taxpayer Actos Suit
A Louisiana federal judge on Thursday threw out a proposed class action alleging that Takeda Pharmaceutical Co. and Eli Lilly & Co. ripped off taxpayers by hiding the risks of their diabetes drug Actos, after the Arkansas Supreme Court ruled the drug was properly prescribed by doctors. In a two-page order granting the defendant’s motion to dismiss for failure to …
Takeda Ordered to Pay for Destroying Actos Files
Bloomberg is reporting that Takeda Pharmaceutical was ordered by a jury to pay $155,000 over its destruction of documents about its Actos diabetes medicine after the panel concluded the missing files blocked a man from proving his claims that the drug caused his cancer. Jurors in state court in Martinsburg, West Virginia, deliberated about three hours today before concluding Takeda …
Actos Update: Takeda Lowers Punitive Damages Penalty
Takeda Pharmaceutical Co. and Eli Lilly & Co. won a more than a 99 percent cut in a $9 billion punitive damages award over claims the drugmakers hid the cancer risks of their Actos diabetes medicine. Jurors properly found officials of Osaka, Japan-based Takeda and Indianapolis-based Lilly intentionally hid the health risks of the drug and should pay punitive damages, …
First Actos Bladder Cancer Suit In W.Va. Goes To Trial
The first trial in West Virginia state court over allegations that Takeda Pharmaceutical Co. Ltd.’s widely prescribed diabetes drug Actos causes bladder cancer begins today, featuring the same plaintiffs firm that has taken Actos cases to trial in four other states and secured three pro-plaintiff verdicts. The West Virginia trial comes shortly after the Miller Firm LLC secured a $2 …
Update: Takeda Ordered to Pay Actos User After Verdict is Reached
As mentioned in previous blog posts, we continue to follow the Actos bellwether trials as they occur across the country. The latest Actos verdict occurred in Philadelphia, PA. in favor of the injured plaintiff. Takeda Pharmaceutical Co. was ordered by a jury to pay more than $2 million to a woman who claimed the company’s Actos diabetes medicine caused her bladder …
Top Product Liability Verdicts Of 2014
The first half of 2014 produced at least five product liability verdicts topping $100 million, underscoring not only the ongoing vigor of long-running asbestos disputes, but the impact that an acrimonious discovery dispute can have on verdict size, as it did with the $6 billion award against Takeda Pharmaceuticals Co. Ltd. Here is a list of all the product liability …
Takeda, Lilly Say Prejudice Infected $9B Actos Verdict
Takeda Pharmaceutical Co. Ltd. and Eli Lilly & Co. argued Friday that the sheer size of the $9 billion punitive damages award they suffered in the bellwether personal injury trial over the diabetes drug Actos demonstrates the jury was inflamed by “passion and prejudice,” saying its verdict should be overturned. Reported as the seventh-largest punitive damages award in U.S. history, the April …
Burned in Federal Court, Takeda Hopes to Find Solace in State Courts Over Actos Drug
Word to the Wise: Plaintiffs should avoid state courts when suing Takeda over their diabetes drug Actos. Why? Because Takeda has been slammed with a $6 billion verdict and disciplined for destroying key evidence in federal court over Actos, but the drugmaker has found success in state courts by convincing juries that it adequately warned of the drug’s bladder cancer …
ACTOS UPDATE: Takeda Destroyed Evidence In Cancer Suit, Judge Says
A Louisiana federal judge said on Friday, June 20th, that Takeda Pharmaceuticals Co. Ltd. intentionally destroyed evidence that would have helped the plaintiffs in a $9 billion bellwether lawsuit over claims the company hid the cancer risks of diabetes drug Actos to keep sales high. The ruling from U.S. District Judge Rebecca Doherty follows plaintiffs Terrence and Susan Allen’s April …
ACTOS UPDATE: (1) Eli Lilly Ducks Perjury Sanctions and (2) Blue Cross Sues Takeda & Eli Lilly
(1) Eli Lilly Ducks Perjury Sanctions In Actos Trial A federal judge on Wednesday declined to sanction Eli Lilly & Co. or subject a former executive to criminal investigation for zig-zagging on the stand during a bellwether trial alleging the diabetes drug Actos caused bladder cancer, saying the questionable testimony hadn’t stopped the plaintiffs from winning a $9 billion verdict. …
Takeda Wins Las Vegas Lawsuit Over Diabetes Drug Actos
A Nevada state jury found for Takeda Pharmaceutical Co. Ltd. on Thursday after a months-long trial in which two elderly women claimed the company’s diabetes drug Actos causes bladder cancer, a victory that follows Takeda’s astounding $6 billion loss earlier this year in a federal suit over the same drug. The jury delivered its verdict after roughly two days …
ACTOS Updates
(1) Takeda Avoids Another Big Loss In Ill. Actos Cancer Trial A jury on Thursday cleared Takeda Pharmaceutical Co. Ltd. of liability in the first trial among thousands of Illinois lawsuits blaming the diabetes drug Actos for causing bladder cancer, following a multibillion-dollar verdict against the drugmaker last month in Louisiana. The 12-member jury — seven men and five women …
Actos Verdict: Jury Orders Takeda, Eli Lilly To Pay Damages
Takeda Pharmaceutical Co. and Eli Lilly & Co. were ordered to pay a combined $9 billion in punitive damages after a federal court jury found they hid the cancer risks of their Actos diabetes medicine in the first U.S. trial of its kind. Osaka, Japan-based Takeda was ordered to pay $6 billion by the jury yesterday in Lafayette, Louisiana. Its …
Actos Trial Continues in Nevada
After three and a half weeks of selecting a jury from a pool of 400 Clark County citizens, the Actos trial continues to play out in Las Vegas, Nevada. The case is noteworthy because the plaintiffs, Bertha Triana and Delores Cipriano, are seeking the largest jury award in Nevada history. Japanese pharmaceutical giant Takeda is accused of failing to inform …
Takeda Jury Can Hear Claims Over Destroyed Actos Files
Bloomberg News is reporting Takeda Pharmaceutical Co. must let a jury hear claims that it intentionally destroyed files related its Actos diabetes drug, a judge ruled before the first federal trial over allegations the pills cause bladder cancer. Officials of Osaka, Japan-based Takeda admitted they can’t find files compiled by 46 current and former employees involved with the development, marketing …
Takeda, makers of Actos, Scraps Development of Type 2 Diabetes Drug
Japanese pharmaceutical company Takeda is dropping plans to develop diabetes drug fasiglifam (TAK-875) because clinical trials showed participants developed dangerous side effects, including possible liver damage. This comes as a blow for the drugmaker as it scrambles to find another drug to take the place of its once best-selling Type 2 diabetes drug Actos. Takeda lost patent protection for Actos …